15mg tirzepatide (GLP-1/GIP) - Zepbound 15 mg/0.5 mL injection
Description
The company aims to be a leader in obesity therapies Late last year, Pfizer completed the acquisition of Metsera, valuing the enterprise at about $7 billion

After surgery recovery, these mice were food restricted to 9095% of their ad libitum body weight (CRM(E), SDS diets)

Unlike other weight loss clinics, which may solely offer pricey diet plans or nutritional advice, we offer holistic treatment to support weight loss that lasts

When paired with a healthy lifestyle, it helps achieve sustainable weight loss

Liraglutide had a similar effect but to a slightly lesser extent, which the authors attribute to differences in doses and treatment approach of the two drugs

While possible, maintaining results after stopping GLP-1 therapy is challenging and requires intensive lifestyle modifications including 200-300 minutes of weekly exercise, consistent dietary changes, regular self-monitoring, and often ongoing behavioral support
